Nanjing Medlander Medical Technology Co. Ltd. A (688273) - Total Assets
Based on the latest financial reports, Nanjing Medlander Medical Technology Co. Ltd. A (688273) holds total assets worth CN¥1.52 Billion CNY (≈ $222.85 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore 688273 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Nanjing Medlander Medical Technology Co. Ltd. A - Total Assets Trend (2020–2024)
This chart illustrates how Nanjing Medlander Medical Technology Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. See Nanjing Medlander Medical Technology Co. shareholders equity for net asset value and shareholders' equity analysis.
Nanjing Medlander Medical Technology Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2024)
Nanjing Medlander Medical Technology Co. Ltd. A's total assets of CN¥1.52 Billion consist of 64.8% current assets and 35.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 29.8% |
| Accounts Receivable | CN¥15.18 Million | 1.0% |
| Inventory | CN¥73.05 Million | 4.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥60.55 Million | 3.9% |
| Goodwill | CN¥41.90 Million | 2.7% |
Asset Composition Trend (2020–2024)
This chart illustrates how Nanjing Medlander Medical Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is Nanjing Medlander Medical Technology Co. worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nanjing Medlander Medical Technology Co. Ltd. A's current assets represent 64.8% of total assets in 2024, an increase from 58.8% in 2020.
- Cash Position: Cash and equivalents constituted 29.8% of total assets in 2024, down from 44.6% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 2.0% in 2020.
- Asset Diversification: The largest asset category is inventory at 4.7% of total assets.
Nanjing Medlander Medical Technology Co. Ltd. A Competitors by Total Assets
Key competitors of Nanjing Medlander Medical Technology Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Insulet Corporation
NASDAQ:PODD
|
USA | $2.99 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Lumexa Imaging Holdings, Inc. Common Stock
NASDAQ:LMRI
|
USA | $1.76 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Epitomee Medical Ltd
TA:EPIT
|
Israel | ILA37.04 Million |
Nanjing Medlander Medical Technology Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 7.88 | 9.39 | 16.82 |
| Quick Ratio | 7.31 | 8.93 | 16.25 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥803.93 Million | CN¥963.61 Million | CN¥1.24 Billion |
Nanjing Medlander Medical Technology Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Nanjing Medlander Medical Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.30 |
| Latest Market Cap to Assets Ratio | 0.39 |
| Asset Growth Rate (YoY) | 0.8% |
| Total Assets | CN¥1.55 Billion |
| Market Capitalization | $605.08 Million USD |
Valuation Analysis
Below Book Valuation: The market values Nanjing Medlander Medical Technology Co. Ltd. A's assets below their book value (0.39x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Nanjing Medlander Medical Technology Co. Ltd. A's assets grew by 0.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Nanjing Medlander Medical Technology Co. Ltd. A (2020–2024)
The table below shows the annual total assets of Nanjing Medlander Medical Technology Co. Ltd. A from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.55 Billion ≈ $226.32 Million |
+0.83% |
| 2023-12-31 | CN¥1.53 Billion ≈ $224.46 Million |
+1.46% |
| 2022-12-31 | CN¥1.51 Billion ≈ $221.24 Million |
+209.35% |
| 2021-12-31 | CN¥488.74 Million ≈ $71.52 Million |
+45.39% |
| 2020-12-31 | CN¥336.15 Million ≈ $49.19 Million |
-- |
About Nanjing Medlander Medical Technology Co. Ltd. A
Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vagina… Read more